PUBLICATIONS

To be updated

• Management of cardiovascular disease using an mHealth tool: a randomized clinical trial.
  Kang SH, Baek H, Cho J, Kim S, Hwang H, Lee W, Park JJ, Yoon YE, Yoon CH, Cho YS, Youn TJ, Cho GY, Chae IH, Choi DJ, Yoo S, Suh JW.
  NPJ Digit Med. 2021 Dec 3;4(1):165. doi: 10.1038/s41746-021-00535-z.

• Impact of statin intensity on adverse cardiac and cerebrovascular events in older adult patients with myocardial infarction.
  Moon IT, Kang SH, Lee W, Cho Y, Park JJ, Yoon YE, Oh IY, Yoon CH, Suh JW, Youn TJ, Chae IH, Choi DJ, Cho YS.
  J Geriatr Cardiol. 2021 Aug 28;18(8):609-622. doi: 10.11909/j.issn.1671-5411.2021.08.005.

• Prognosis of Atrial Fibrillation Patients Undergoing PCI According to Anticoagulants and Antiplatelet Agents.
  Yoon GS, Kim SH, Kang SH, Yoon CH, Cho YS, Youn TJ, Chae IH.
  J Clin Med. 2021 Jul 29;10(15):3370. doi: 10.3390/jcm10153370.

• The Korean Hypertension Cohort study: design and baseline characteristics.
  Lee HY, Lee JY, Shin HG, Cho SH, Park KI, Oh GC, Lee SP, Kim H, Lee HS, Kim KI, Kang SH, Lee JH, Jang SY, Lee JH, Kim KH, Cho JY, Park JH, Jang J, Park SK, Bak JK.
  Korean J Intern Med. 2021 Sep;36(5):1115-1125. doi: 10.3904/kjim.2020.551. Epub 2021 Jul 22.

• Hypertension, renin-angiotensin-aldosterone-system-blocking agents, and COVID-19.
  Kang SH, Lee DH, Han KD, Jung JH, Park SH, Dai AM, Wei HG, Yoon CH, Youn TJ, Chae IH, Kim CH.
  Clin Hypertens. 2021 Jun 1;27(1):11. doi: 10.1186/s40885-021-00168-0.

• Pre-existing and machine learning-based models for cardiovascular risk prediction.
  Cho SY, Kim SH, Kang SH, Lee KJ, Choi D, Kang S, Park SJ, Kim T, Yoon CH, Youn TJ, Chae IH.
  Sci Rep. 2021 Apr 26;11(1):8886. doi: 10.1038/s41598-021-88257-w.

• Office Blood Pressure Range and Cardiovascular Events in Patients With Hypertension: A Nationwide Cohort Study in South Korea.
  Kwon CH, Kim W, Shin JH, Lee CJ, Kim HC, Kang SH, Jung MH, Kim DH, Lee JH, Kim HL, Kim HM, Cho IJ, Cho I, Kang DR, Lee HY, Chung WJ, Ihm SH, Kim KI, Cho EJ, Sohn IS, Park S, Shin J, Ryu SK, Kang SM, Cho MC, Kim JH, Lee JH, Kim JY, Pyun WB, Sung KC.
  J Am Heart Assoc. 2021 Apr 6;10(7):e017890. doi: 10.1161/JAHA.120.017890. Epub 2021 Mar 19.

• Disparities in Mortality and Cardiovascular Events by Income and Blood Pressure Levels Among Patients With Hypertension in South Korea.
  Shin JH, Jung MH, Kwon CH, Lee CJ, Kim DH, Kim HL, Kim W, Kang SH, Lee JH, Kim HM, Cho IJ, Cho I, Lee JH, Kang DR, Lee HY, Chung WJ, Ihm SH, Kim KI, Cho EJ, Sohn IS, Kim HC, Park S, Shin J, Kim JH, Ryu SK, Kang SM, Pyun WB, Cho MC, Sung KC.
  J Am Heart Assoc. 2021 Apr 6;10(7):e018446. doi: 10.1161/JAHA.120.018446. Epub 2021 Mar 15.

• Antihypertensive Drugs and the Risk of Cancer: A Nationwide Cohort Study.
  Cho IJ, Shin JH, Jung MH, Kang CY, Hwang J, Kwon CH, Kim W, Kim DH, Lee CJ, Kang SH, Lee JH, Kim HL, Kim HM, Cho I, Lee HY, Chung WJ, Ihm SH, Kim KI, Cho EJ, Sohn IS, Park S, Shin J, Ryu SK, Kim JY, Kang SM, Cho MC, Pyun WB, Sung KC.
  J Clin Med. 2021 Feb 15;10(4):771. doi: 10.3390/jcm10040771.

• Evaluation of Heart-type Fatty Acid-binding Protein in Early Diagnosis of Acute Myocardial Infarction.
  Moon MG, Yoon CH, Lee K, Kang SH, Youn TJ, Chae IH.
  J Korean Med Sci. 2021 Mar 1;36(8):e61. doi: 10.3346/jkms.2021.36.e61.

• Long-term Prognosis of Mild to Moderate Aortic Stenosis and Coronary Artery Disease.
  Lee W, Choi W, Kang SH, Hwang IC, Choi HM, Yoon YE, Cho GY.
  J Korean Med Sci. 2021 Feb 8;36(6):e47. doi: 10.3346/jkms.2021.36.e47.

• Effect of angiotensin receptor blockers on the development of cancer: A nationwide cohort study in korea.
  Jung MH, Lee JH, Lee CJ, Shin JH, Kang SH, Kwon CH, Kim DH, Kim WH, Kim HL, Kim HM, Cho IJ, Cho I, Hwang J, Ryu S, Kang C, Lee HY, Chung WJ, Ihm SH, Kim KI, Cho EJ, Sohn IS, Park S, Shin J, Ryu SK, Rhee MY, Kang SM, Pyun WB, Cho MC, Sung KC.
  J Clin Hypertens (Greenwich). 2021 Apr;23(4):879-887. doi: 10.1111/jch.14187. Epub 2021 Jan 25.

• BioMatrix versus Orsiro biodegradable polymer stents in all-comer patients with coronary artery disease: the multicentre, randomised BIODEGRADE trial.
  Yoon CH, Choi YJ, Park JJ, Kang SH, Kim SH, Suh JW, Cho YS, Youn TJ, Kim MK, Cha KS, Lee SH, Hong BK, Rha SW, Kang WC, Lee JH, Kim SH, Chae IH; Collaborators.
  EuroIntervention. 2021 Apr 20;16(17):1404-1412. doi: 10.4244/EIJ-D-20-00185.

• Comparison of Continuous ECG Monitoring by Wearable Patch Device and Conventional Telemonitoring Device.
  Choi W, Kim SH, Lee W, Kang SH, Yoon CH, Youn TJ, Chae IH.
  J Korean Med Sci. 2020 Nov 16;35(44):e363. doi: 10.3346/jkms.2020.35.e363.

• Incident cardiovascular disease and particulate matter air pollution in South Korea using a population-based and nationwide cohort of 0.2 million adults.
  Kim OJ, Lee SH, Kang SH, Kim SY.
  Environ Health. 2020 Nov 9;19(1):113. doi: 10.1186/s12940-020-00671-1.

• Blood pressure levels and cardiovascular risk according to age in patients with diabetes mellitus: a nationwide population-based cohort study.
  Kim HL, Kim HM, Kwon CH, Shin JH, Jung MH, Lee CJ, Kim DH, Kim WH, Kang SH, Lee JH, Cho IJ, Cho I, Lee JH, Kang DR, Lee HY, Chung WJ, Ihm SH, Kim KI, Cho EJ, Sohn IS, Kim HC, Shin J, Kim JH, Ryu SK, Kang SM, Pyun WB, Cho MC, Park S, Sung KC.
  Cardiovasc Diabetol. 2020 Oct 19;19(1):181. doi: 10.1186/s12933-020-01156-8.

• Effect of Ticagrelor on Left Ventricular Remodeling in Patients With ST-Segment Elevation Myocardial Infarction (HEALING-AMI).
  Park Y, Koh JS, Lee JH, Park JH, Shin ES, Oh JH, Chun W, Lee SY, Bae JW, Kim JS, Kim W, Suh JW, Yang DH, Hong YJ, Chan MY, Kang MG, Park HW, Hwang SJ, Hwang JY, Ahn JH, Choi SW, Jeong YH; HEALING-AMI Investigators.
  JACC Cardiovasc Interv. 2020 Oct 12;13(19):2220-2234. doi: 10.1016/j.jcin.2020.08.007.

• Personal exposure to fine particulate air pollutants impacts blood pressure and heart rate variability.
  Lee DH, Kim SH, Kang SH (corr), Kwon OK, Park JJ, Yoon CH, Cho YS, Heo J, Yi SM, Youn TJ, Chae IH.
  Sci Rep. 2020 Oct 6;10(1):16538. doi: 10.1038/s41598-020-73205-x.

• New-onset paroxysmal atrial fibrillation in acute myocardial infarction: increased risk of stroke.
  Lee JH, Kim SH, Lee W, Cho Y, Kang SH, Park JJ, Oh IY, Yoon CH, Suh JW, Cho YS, Youn TJ, Chae IH, Choi DJ.
  BMJ Open. 2020 Sep 23;10(9):e039600. doi: 10.1136/bmjopen-2020-039600.

• BioMatrix versus Orsiro Stent for Coronary Artery Disease: A Multicenter, Randomized, Open-Label Study.
  Yoon CH, Choi YJ, Park JJ, Kang SH, Kim SH, Suh JW, Cho YS, Youn TJ, Kim MK, Cha KS, Lee SH, Hong BK, Rha SW, Kang WC, Lee JH, Kim SH, Chae IH; Collaborators.
  EuroIntervention. 2020 Sep 22:EIJ-D-20-00185. doi: 10.4244/EIJ-D-20-00185. Online ahead of print.

• Validation of the diagnostic performance of 'HeartMedi V.1.0', a novel CT-derived fractional flow reserve measurement, for patients with coronary artery disease: a study protocol.
  Kim SH, Kang SH (co-1st), Chung WY, Yoon CH, Park SD, Nam CW, Kwon KH, Doh JH, Byun YS, Bae JW, Youn TJ, Chae IH.
  BMJ Open. 2020 Jul 20;10(7):e037780. doi: 10.1136/bmjopen-2020-037780.

• Risk of osteoporotic fracture in older patients under antihypertensive treatment.
  Kwon OK, Kim SH, Kang SH (corr), Lee YK, Yoon CH, Lee HY, Youn TJ, Chae IH, Kim CH.
  Eur J Prev Cardiol. 2020 May 9:2047487320923054. doi: 10.1177/2047487320923054. Online ahead of print.

• Prediction of Intracranial Aneurysm Risk using Machine Learning.
  Heo J, Park SJ, Kang SH, Oh CW, Bang JS, Kim T.
  Sci Rep. 2020 Apr 24;10(1):6921. doi: 10.1038/s41598-020-63906-8.

• Comparison of Shear Stress-Induced Thrombotic and Thrombolytic Effects Among 3 Different Antithrombotic Regimens in Patients With Acute Coronary Syndrome.
  Kim M, Kang SH, Kim JR, Park JJ, Cho YS, Youn TJ, Chae IH, Suh JW.
  Clin Appl Thromb Hemost. 2020 Jan-Dec;26:1076029620912814. doi: 10.1177/1076029620912814.

• Effects of Hypertension, Diabetes, and Smoking on Age and Sex Prediction from Retinal Fundus Images.
  Kim YD, Noh KJ, Byun SJ, Lee S, Kim T, Sunwoo L, Lee KJ, Kang SH, Park KH, Park SJ.
  Sci Rep. 2020 Mar 12;10(1):4623. doi: 10.1038/s41598-020-61519-9.

• Medication persistence and adherence: A key approach to improve hypertension management.
  Cho HW, Kang SH (corr), Kim CH.
  Eur J Prev Cardiol. 2020 Feb 24:2047487320905191. doi: 10.1177/2047487320905191.

• Potential impact of 2018 Korean Society of Hypertension guidelines on Korean population: a population-based cohort study.
  Kwun JS, Kim SH, Kang SH (corr), Yoon CH, Lee HY, Kim KI, Youn TJ, Chae IH, Kim CH.
  Clin Hypertens. 2020 Feb 1;26:3. doi: 10.1186/s40885-020-0137-5. eCollection 2020.

• Polymer-based or Polymer-free Stents in Patients at High Bleeding Risk.
  Windecker S, Latib A, Kedhi E, Kirtane AJ, Kandzari DE, Mehran R, Price MJ, Abizaid A, Simon DI, Worthley SG, Zaman A, Hudec M, Poliacikova P, Abdul Ghapar AKB, Selvaraj K, Petrov I, Mylotte D, Pinar E, Moreno R, Fabbiocchi F, Pasupati S, Kim HS, Aminian A, Tie C, Wlodarczak A, Hur SH, Marx SO, Jankovic I, Brar S, Bousquette L, Liu M, Stone GW; ONYX ONE Investigators.
  N Engl J Med. 2020 Mar 26;382(13):1208-1218. doi: 10.1056/NEJMoa1910021. Epub 2020 Feb 12.

• Three-year clinical outcome of biodegradable hybrid polymer Orsiro sirolimus-eluting stent and the durable biocompatible polymer Resolute Integrity zotarolimus-eluting stent: A randomized controlled trial.
  Kim SH, Kang SH, Lee JM, Chung WY, Park JJ, Yoon CH, Suh JW, Cho YS, Doh JH, Cho JM, Bae JW, Youn TJ, Chae IH.
  Catheter Cardiovasc Interv. 2020 Dec;96(7):1399-1406. doi: 10.1002/ccd.28654. Epub 2019 Dec 20.

• Short-term effects of air pollution on blood pressure.
  Choi YJ, Kim SH, Kang SH (corr), Kim SY, Kim OJ, Yoon CH, Lee HY, Youn TJ, Chae IH, Kim CH.
  Sci Rep. 2019 Dec 30;9(1):20298. doi: 10.1038/s41598-019-56413-y.

• Three-year clinical outcome of biodegradable hybrid polymer Orsiro sirolimus-eluting stent and the durable biocompatible polymer Resolute Integrity zotarolimus-eluting stent: A randomized controlled trial.
  Kim SH, Kang SH (co-1st), Lee JM, Chung WY, Park JJ, Yoon CH, Suh JW, Cho YS, Doh JH, Cho JM, Bae JW, Youn TJ, Chae IH.
  Catheter Cardiovasc Interv. 2019 Dec 20. doi: 10.1002/ccd.28654. Online ahead of print.

• Differential Effect of β-Blockers According to Heart Rate in Acute Myocardial Infarction Without Heart Failure or Left Ventricular Systolic Dysfunction: A Cohort Study.
  Park JJ, Kim SH, Kang SH, Yoon CH, Suh JW, Cho YS, Youn TJ, Chae IH, Choi DJ.
  Mayo Clin Proc. 2019 Dec;94(12):2476-2487. doi: 10.1016/j.mayocp.2019.05.033.

• Differential impact of smoking on cardiac or non-cardiac death according to age.
  Choi W, Kim SH, Kang SH, Park JJ, Yoon CH, Youn TJ, Chae IH.
  PLoS One. 2019 Oct 30;14(10):e0224486. doi: 10.1371/journal.pone.0224486. eCollection 2019.

• Mortality reduction with physical activity in patients with and without cardiovascular disease.
  Jeong SW, Kim SH, Kang SH (corr), Kim HJ, Yoon CH, Youn TJ, Chae IH.
  Eur Heart J. 2019 Nov 14;40(43):3547-3555. doi: 10.1093/eurheartj/ehz564.

• PM2.5 concentration in the ambient air is a risk factor for the development of high-risk coronary plaques
  Yang S, Lee SP, Park JB, Lee H, Kang SH, Lee SE, Kim JB, Choi SY, Kim YJ, Chang HJ.
  Eur Heart J Cardiovasc Imaging. 2019 Dec 1;20(12):1355-1364. doi: 10.1093/ehjci/jez209.

• Prevalence, Awareness, Treatment, and Control of Hypertension in Korea.
  Kang SH , Kim SH, Cho JH, Yoon CH, Hwang SS, Lee HY, Youn TJ, Chae IH, Kim CH.
  Sci Rep. 2019 Jul 29;9(1):10970. doi: 10.1038/s41598-019-46965-4.

• Comparison of patency between two different peripheral self-expandable stents, absolute Pro® versus complete SE® in femoropopliteal occlusive disease.
  Han D, Kang SH, Kim SH, Yoon CH, Chae IH.
  Int Angiol. 2019 Aug;38(4):305-311. doi: 10.23736/S0392-9590.19.04102-6. Epub 2019 Jul 24.

• Hemodynamically balanced congenitally corrected transposition of the great arteries with a large ventricular septal defect, and subvalvular pulmonic stenosis: a case report.
  Cho SY, Yoon YE, Lee W, Kang SH, Song YH, Lim C, Cho GY, Seo JW.
  J Med Case Rep. 2019 Jul 19;13(1):219. doi: 10.1186/s13256-019-2145-1.

• Retrospective study of prognosis and relating factors of cardiac complications associated with electrical injuries at a single centre in Korea.
  Choi JH, Han D, Kang SH, Yoon CH, Cho JR, Kym D.
  BMJ Open. 2019 Jul 10;9(7):e028741. doi: 10.1136/bmjopen-2018-028741.

• Comparison of Minimally Invasive Direct Coronary Artery Bypass and Percutaneous Coronary Intervention Using Second-Generation Drug-Eluting Stents for Coronary Artery Disease　- Propensity Score-Matched Analysis.
  Choi W, Chang HW, Kang SH, Yoon CH, Cho YS, Youn TJ, Chae IH, Kim DJ, Kim JS, Park KH, Kim HS, Lim C, Suh JW.
  Circ J. 2019 Jun 25;83(7):1572-1580. doi: 10.1253/circj.CJ-18-1330. Epub 2019 May 24.

• Association of short- and long-term exposure to air pollution with atrial fibrillation.
  Kwon OK, Kim SH, Kang SH (corr), Cho Y, Oh IY, Yoon CH, Kim SY, Kim OJ, Choi EK, Youn TJ, Chae IH.
  Eur J Prev Cardiol. 2019 Jul;26(11):1208-1216. doi: 10.1177/2047487319835984. Epub 2019 Mar 12.

• Clinical and Computed Tomography Angiographic Predictors of Coronary Lesions That Later Progressed to Chronic Total Occlusion.
  Kang J, Chun EJ, Park HJ, Cho YS, Park JJ, Kang SH, Cho YJ, Yoon YE, Oh IY, Yoon CH, Suh JW, Youn TJ, Chae IH, Choi DJ.
  JACC Cardiovasc Imaging. 2019 Nov;12(11 Pt 1):2196-2206. doi: 10.1016/j.jcmg.2018.12.026. Epub 2019 Feb 13.

• Machine learning for detecting moyamoya disease in plain skull radiography using a convolutional neural network.
  Kim T, Heo J, Jang DK, Sunwoo L, Kim J, Lee KJ, Kang SH, Park SJ, Kwon OK, Oh CW.
  EBioMedicine. 2019 Feb;40:636-642. doi: 10.1016/j.ebiom.2018.12.043. Epub 2018 Dec 29.

• Improved oral hygiene care attenuates the cardiovascular risk of oral health disease: a population-based study from Korea.
  Park SY, Kim SH, Kang SH (corr), Yoon CH, Lee HJ, Yun PY, Youn TJ, Chae IH.
  Eur Heart J. 2019 Apr 7;40(14):1138-1145. doi: 10.1093/eurheartj/ehy836.

• Reconsidering the cut-off diastolic blood pressure for predicting cardiovascular events: a nationwide population-based study from Korea.
  Choi YJ, Kim SH, Kang SH (corr), Yoon CH, Lee HY, Youn TJ, Chae IH, Kim CH.
  Eur Heart J. 2019 Mar 1;40(9):724-731. doi: 10.1093/eurheartj/ehy801.

• Blood Pressure Control and Cardiovascular Outcomes: Real-world Implications of the 2017 ACC/AHA Hypertension Guideline.
  Lee JH, Kim SH, Kang SH (corr), Cho JH, Cho Y, Oh IY, Yoon CH, Lee HY, Youn TJ, Chae IH, Kim CH.
  Sci Rep. 2018 Sep 3;8(1):13155. doi: 10.1038/s41598-018-31549-5.

• Prediction of Subclinical Coronary Artery Disease With Breast Arterial Calcification and Low Bone Mass in Asymptomatic Women: Registry for the Women Health Cohort for the BBC Study.
  Yoon YE, Kim KM, Han JS, Kang SH, Chun EJ, Ahn S, Kim SM, Choi SI, Yun B, Suh JW.
  JACC Cardiovasc Imaging. 2019 Jul;12(7 Pt 1):1202-1211. doi: 10.1016/j.jcmg.2018.07.004. Epub 2018 Aug 15.

• Intravascular imaging analysis of a drug-eluting balloon followed by a bare metal stent compared to a drug-eluting stent for treatment of de novo lesions.
  Choi W, Chae IH, Park JJ, Kim SH, Kang SH, Oh IY, Yoon CH, Cho YS, Youn TJ, Choi DJ.
  Korean J Intern Med. 2019 Jul;34(4):819-829. doi: 10.3904/kjim.2017.378. Epub 2018 Jul 4.

• Relevance of Antiplatelet Therapy Duration After Stent-Assisted Coil Embolization for Unruptured Intracranial Aneurysms.
  Kim T, Kim CH, Kang SH, Ban SP, Kwon OK.
  World Neurosurg. 2018 Aug;116:e699-e708. doi: 10.1016/j.wneu.2018.05.071. Epub 2018 May 17.

• Experiences of magnetic resonance imaging scanning in patients with pacemakers or implantable cardioverter-defibrillators.
  Han D, Kang SH, Cho Y, Oh IY.
  Korean J Intern Med. 2019 Jan;34(1):99-107. doi: 10.3904/kjim.2017.251. Epub 2018 Apr 4.

• Effect of β-Blockers Beyond 3 Years After Acute Myocardial Infarction.Park JJ, Kim SH, Kang SH, Yoon CH, Cho YS, Youn TJ, Chae IH, Choi DJ.J Am Heart Assoc. 2018 Mar 3;7(5):e007567. doi: 10.1161/JAHA.117.007567.

• Cardiac Auscultation Using Smartphones: Pilot Study.Kang SH, Joe B, Yoon Y, Cho GY, Shin I, Suh JW.JMIR Mhealth Uhealth. 2018 Feb 28;6(2):e49. doi: 10.2196/mhealth.8946.

• Prediction of infarct size and adverse cardiac outcomes by tissue tracking-cardiac magnetic resonance imaging in ST-segment elevation myocardial infarction.Yoon YE, Kang SH, Choi HM, Jeong S, Sung JM, Lee SE, Cho I, Cho GY, Chang HJ, Chun EJ.Eur Radiol. 2018 Aug;28(8):3454-3463. doi: 10.1007/s00330-017-5296-8. Epub 2018 Feb 15.

• Long-term cardiovascular risk of hypertensive events in emergency department: A population-based 10-year follow-up study.Lee S, You CY, Kim J, Jo YH, Ro YS, Kang SH, Lee H.PLoS One. 2018 Feb 15;13(2):e0191738. doi: 10.1371/journal.pone.0191738. eCollection 2018.

• Enhancing User Experience Through User Study: Design of an mHealth Tool for Self-Management and Care Engagement of Cardiovascular Disease Patients.Baek H, Suh JW, Kang SH, Kang S, Lim TH, Hwang H, Yoo S.JMIR Cardio. 2018 Feb 9;2(1):e3. doi: 10.2196/cardio.9000.

• Increased epicardial adipose tissue thickness is a predictor of new-onset diabetes mellitus in patients with coronary artery disease treated with high-intensity statins.Kang J, Kim YC, Park JJ, Kim S, Kang SH, Cho YJ, Yoon YE, Oh IY, Yoon CH, Suh JW, Cho YS, Youn TJ, Chae IH, Choi DJ.Cardiovasc Diabetol. 2018 Jan 11;17(1):10. doi: 10.1186/s12933-017-0650-3.

• Risk of Pneumonia After Vertebral Compression Fracture in Women With Low Bone Density: A Population-Based Study.Kim B, Kim J, Jo YH, Kang SH, Lee YJ, Lee JH, Hwang JE, Park MJ, Lee S.Spine (Phila Pa 1976). 2018 Jul 15;43(14):E830-E835. doi: 10.1097/BRS.0000000000002536.

• Long-term safety of bioresorbable scaffolds: insights from a network meta-analysis including 91 trials.Kang SH, Gogas BD, Jeon KH, Park JS, Lee W, Yoon CH, Suh JW, Hwang SS, Youn TJ, Chae IH, Kim HS.EuroIntervention. 2018 Mar 20;13(16):1904-1913. doi: 10.4244/EIJ-D-17-00646.

• Cardiovascular Effects of Long-Term Exposure to Air Pollution: A Population-Based Study With 900 845 Person-Years of Follow-up.Kim H, Kim J, Kim S, Kang SH (corr), Kim HJ, Kim H, Heo J, Yi SM, Kim K, Youn TJ, Chae IH.J Am Heart Assoc. 2017 Nov 8;6(11):e007170. doi: 10.1161/JAHA.117.007170.

• Association between adult height, myocardial infarction, heart failure, stroke and death: a Korean nationwide population-based study.Park CS, Choi EK, Han KD, Lee HJ, Rhee TM, Lee SR, Cha MJ, Lim WH, Kang SH, Oh S.Int J Epidemiol. 2018 Feb 1;47(1):289-298. doi: 10.1093/ije/dyx175.

• Increased Risk of Atrial Fibrillation and Thromboembolism in Patients with Severe Psoriasis: a Nationwide Population-based Study.Rhee TM, Lee JH, Choi EK, Han KD, Lee H, Park CS, Hwang D, Lee SR, Lim WH, Kang SH, Cha MJ, Cho Y, Oh IY, Oh S.Sci Rep. 2017 Aug 30;7(1):9973. doi: 10.1038/s41598-017-10556-y.

• Risk of stroke in congestive heart failure with and without atrial fibrillation.Kang SH, Kim J, Park JJ, Oh IY, Yoon CH, Kim HJ, Kim K, Choi DJ.Int J Cardiol. 2017 Dec 1;248:182-187. doi: 10.1016/j.ijcard.2017.07.056. Epub 2017 Jul 20.

• Hemostasis pad combined with compression device after transradial coronary procedures: A randomized controlled trial.Kang SH, Han D, Kim S, Yoon CH, Park JJ, Suh JW, Cho YS, Youn TJ, Chae IH.PLoS One. 2017 Jul 24;12(7):e0181099. doi: 10.1371/journal.pone.0181099. eCollection 2017.

• Proteinuria Detected by Urine Dipstick Test as a Risk Factor for Atrial Fibrillation: A Nationwide Population-Based Study.Lim WH, Choi EK, Han KD, Rhee TM, Lee HJ, Lee SR, Kang SH, Cha MJ, Oh S.Sci Rep. 2017 Jul 24;7(1):6324. doi: 10.1038/s41598-017-06579-0.

• Relation between secondhand smoke exposure and cardiovascular risk factors in never smokers.Kim S, Kang SH, Han D, Kim SH, Kim HJ, Park JJ, Cho Y, Yoon YE, Han KD, Oh IY, Yoon CH, Suh JW, Lee HY, Cho YS, Youn TJ, Cho GY, Chae IH, Choi DJ, Kim CH.J Hypertens. 2017 Oct;35(10):1976-1982. doi: 10.1097/HJH.0000000000001426.

• Cirrhosis is a risk factor for atrial fibrillation: A nationwide, population-based study.Lee H, Choi EK, Rhee TM, Lee SR, Lim WH, Kang SH, Han KD, Cha MJ, Oh S.Liver Int. 2017 Nov;37(11):1660-1667. doi: 10.1111/liv.13459. Epub 2017 May 26.

• Risk of Ischemic Stroke in Patients With Non-Valvular Atrial Fibrillation Not Receiving Oral Anticoagulants　- Korean Nationwide Population-Based Study.Kang SH, Choi EK, Han KD, Lee SR, Lim WH, Cha MJ, Cho Y, Oh IY, Oh S.Circ J. 2017 Jul 25;81(8):1158-1164. doi: 10.1253/circj.CJ-16-1267. Epub 2017 Apr 12.

• Atrial fibrillation risk in metabolically healthy obesity: A nationwide population-based study.Lee H, Choi EK, Lee SH, Han KD, Rhee TM, Park CS, Lee SR, Choe WS, Lim WH, Kang SH, Cha MJ, Oh S.Int J Cardiol. 2017 Aug 1;240:221-227. doi: 10.1016/j.ijcard.2017.03.103. Epub 2017 Mar 28.

• Angiographic outcomes of Orsiro biodegradable polymer sirolimus-eluting stents and Resolute Integrity durable polymer zotarolimus-eluting stents: results of the ORIENT trial.Kang SH, Chung WY, Lee JM, Park JJ, Yoon CH, Suh JW, Cho YS, Doh JH, Cho JM, Bae JW, Youn TJ, Chae IH.EuroIntervention. 2017 Jan 20;12(13):1623-1631. doi: 10.4244/EIJ-D-16-00179.

• Usefulness of Preoperative Echocardiography to Predict Acute Kidney Injury and Long-Term Mortality After Coronary Artery Bypass Grafting.Han SS, Park S, Kang SH, Cho GY, Kim DK, Kim S, Chin HJ, Chae DW, Na KY.Am J Cardiol. 2017 Jan 15;119(2):231-236. doi: 10.1016/j.amjcard.2016.09.054. Epub 2016 Oct 7.

• Evaluation of the association between diabetic retinopathy and the incidence of atrial fibrillation: A nationwide population-based study.Lee SR, Choi EK, Rhee TM, Lee HJ, Lim WH, Kang SH, Han KD, Cha MJ, Cho Y, Oh IY, Oh S.Int J Cardiol. 2016 Nov 15;223:953-957. doi: 10.1016/j.ijcard.2016.08.296. Epub 2016 Aug 21.

• Cigarette Smoking Does Not Enhance Clopidogrel Responsiveness After Adjusting VerifyNow P2Y12 Reaction Unit for the Influence of Hemoglobin Level.Kim YG, Suh JW, Kang SH, Park JJ, Yoon CH, Cho YS, Youn TJ, Chae IH, Choi DJ, Kim HS.JACC Cardiovasc Interv. 2016 Aug 22;9(16):1680-90. doi: 10.1016/j.jcin.2016.05.036.

• Heat, heat waves, and out-of-hospital cardiac arrest.Kang SH, Oh IY, Heo J, Lee H, Kim J, Lim WH, Cho Y, Choi EK, Yi SM, Sang do S, Kim H, Youn TJ, Chae IH, Oh S.Int J Cardiol. 2016 Oct 15;221:232-7. doi: 10.1016/j.ijcard.2016.07.071. Epub 2016 Jul 5.

• Stent Thrombosis With Drug-Eluting Stents and Bioresorbable Scaffolds: Evidence From a Network Meta-Analysis of 147 Trials.Kang SH, Chae IH, Park JJ, Lee HS, Kang DY, Hwang SS, Youn TJ, Kim HS.JACC Cardiovasc Interv. 2016 Jun 27;9(12):1203-12. doi: 10.1016/j.jcin.2016.03.038. Epub 2016 Jun 1.

• Underweight is a risk factor for atrial fibrillation: A nationwide population-based study.Kang SH, Choi EK, Han KD, Lee SR, Lim WH, Cha MJ, Cho Y, Oh IY, Oh S.Int J Cardiol. 2016 Jul 15;215:449-56. doi: 10.1016/j.ijcard.2016.04.036. Epub 2016 Apr 14.

• Ambient air pollution and out-of-hospital cardiac arrest.Kang SH, Heo J, Oh IY, Kim J, Lim WH, Cho Y, Choi EK, Yi SM, Do Shin S, Kim H, Oh S.Int J Cardiol. 2016 Jan 15;203:1086-92. doi: 10.1016/j.ijcard.2015.11.100. Epub 2015 Nov 18.

• Prognostic value of NT-proBNP in heart failure with preserved versus reduced EF.Kang SH, Park JJ, Choi DJ, Yoon CH, Oh IY, Kang SM, Yoo BS, Jeon ES, Kim JJ, Cho MC, Chae SC, Ryu KH, Oh BH; KorHF Registry.Heart. 2015 Dec;101(23):1881-8. doi: 10.1136/heartjnl-2015-307782. Epub 2015 Aug 28.

• Comparison of outcomes after percutaneous coronary intervention for chronic total occlusion using everolimus- versus sirolimus- versus paclitaxel-eluting stents (from the Korean National Registry of Chronic Total Occlusion Intervention).Lee MH, Lee JM, Kang SH, Yoon CH, Jang Y, Yu CW, Park HS, Lee SH, Hur SH, Kim MH, Rha SW, Gwon HC, Chae IH, Kim HS.Am J Cardiol. 2015 Jul 15;116(2):195-203. doi: 10.1016/j.amjcard.2015.04.010. Epub 2015 Apr 16.

• Cardiac resynchronization therapy and QRS duration: systematic review, meta-analysis, and meta-regression.Kang SH, Oh IY, Kang DY, Cha MJ, Cho Y, Choi EK, Hahn S, Oh S.J Korean Med Sci. 2015 Jan;30(1):24-33. doi: 10.3346/jkms.2015.30.1.24. Epub 2014 Dec 23.

• Everolimus-eluting Xience v/Promus versus zotarolimus-eluting resolute stents in patients with diabetes mellitus.Park KW, Lee JM, Kang SH, Ahn HS, Kang HJ, Koo BK, Rhew JY, Hwang SH, Lee SY, Kang TS, Kwak CH, Hong BK, Yu CW, Seong IW, Ahn T, Lee HC, Lim SW, Kim HS.JACC Cardiovasc Interv. 2014 May;7(5):471-81. doi: 10.1016/j.jcin.2013.12.201.

• A randomized comparison of platinum chromium-based everolimus-eluting stents versus cobalt chromium-based Zotarolimus-Eluting stents in all-comers receiving percutaneous coronary intervention: HOST-ASSURE (harmonizing optimal strategy for treatment of coronary artery stenosis-safety & effectiveness of drug-eluting stents & anti-platelet regimen), a randomized, controlled, noninferiority trial.Park KW, Kang SH, Kang HJ, Koo BK, Park BE, Cha KS, Rhew JY, Jeon HK, Shin ES, Oh JH, Jeong MH, Kim S, Hwang KK, Yoon JH, Lee SY, Park TH, Moon KW, Kwon HM, Hur SH, Ryu JK, Lee BR, Park YW, Chae IH, Kim HS; HOST–ASSURE Investigators.J Am Coll Cardiol. 2014 Jul 1;63(25 Pt A):2805-16. doi: 10.1016/j.jacc.2014.04.013. Epub 2014 May 7.

• The impact of residual coronary lesions on clinical outcomes after percutaneous coronary intervention: Residual SYNTAX score after percutaneous coronary intervention in patients from the Efficacy of Xience/Promus versus Cypher in rEducing Late Loss after stENTing (EXCELLENT) registry.Park KW, Kang J, Kang SH, Ahn HS, Kang HJ, Koo BK, Chae IH, Youn TJ, Oh BH, Park YB, Kandzari D, Kim HS.Am Heart J. 2014 Mar;167(3):384-392.e5. doi: 10.1016/j.ahj.2013.09.015. Epub 2013 Oct 17.

• Biodegradable-polymer drug-eluting stents vs. bare metal stents vs. durable-polymer drug-eluting stents: a systematic review and Bayesian approach network meta-analysis.Kang SH, Park KW, Kang DY, Lim WH, Park KT, Han JK, Kang HJ, Koo BK, Oh BH, Park YB, Kandzari DE, Cohen DJ, Hwang SS, Kim HS.Eur Heart J. 2014 May;35(17):1147-58. doi: 10.1093/eurheartj/eht570. Epub 2014 Jan 23.

• Everolimus-eluting versus sirolimus-eluting coronary stents in patients with and without diabetes mellitus.Kang SH, Park KH, Ahn HS, Park KW, Hong YJ, Koo BK, Jeong MH, Kim HS.EuroIntervention. 2014 May;10(1):74-82. doi: 10.4244/EIJV10I1A13.

• Differential prognostic impacts of diabetes over time course after acute myocardial infarction.Kim HL, Kang SH, Yoon CH, Cho YS, Youn TJ, Cho GY, Chae IH, Kim HS, Chae SC, Cho MC, Kim YJ, Kim JH, Ahn Y, Jeong MH, Choi DJ; Other Korea Acute Myocardial Infarction Registry (KAMIR) and Korea Working Group on Myocardial Infarction (KorMI) Investigators.J Korean Med Sci. 2013 Dec;28(12):1749-55. doi: 10.3346/jkms.2013.28.12.1749. Epub 2013 Nov 26.

• Early- and late-term clinical outcome and their predictors in patients with ST-segment elevation myocardial infarction and non-ST-segment elevation myocardial infarction.Park HW, Yoon CH, Kang SH, Choi DJ, Kim HS, Cho MC, Kim YJ, Chae SC, Yoon JH, Gwon HC, Ahn YK, Jeong MH; KAMIR/KorMI Registry.Int J Cardiol. 2013 Nov 15;169(4):254-61. doi: 10.1016/j.ijcard.2013.08.132. Epub 2013 Sep 8.

• Adjunctive cilostazol versus double-dose clopidogrel after drug-eluting stent implantation: the HOST-ASSURE randomized trial (Harmonizing Optimal Strategy for Treatment of Coronary Artery Stenosis-Safety & Effectiveness of Drug-Eluting Stents & Anti-platelet Regimen).Park KW, Kang SH, Park JJ, Yang HM, Kang HJ, Koo BK, Park BE, Cha KS, Rhew JY, Jeon HK, Shin ES, Oh JH, Jeong MH, Kim S, Hwang KK, Yoon JH, Lee SY, Park TH, Moon KW, Kwon HM, Chae IH, Kim HS.JACC Cardiovasc Interv. 2013 Sep;6(9):932-42. doi: 10.1016/j.jcin.2013.04.022.

• Usefulness of the SYNTAX and clinical SYNTAX scores in predicting clinical outcome after unrestricted use of sirolimus- and everolimus-eluting Stents.Park KW, Kang J, Kang SH, Ahn HS, Lee HY, Kang HJ, Koo BK, Chae IH, Youn TJ, Oh BH, Park YB, Kandzari DE, Kim HS.Circ J. 2013;77(12):2912-21. doi: 10.1253/circj.cj-13-0645. Epub 2013 Sep 18.

• Everolimus- versus sirolimus-eluting stents for the treatment of unprotected left main coronary artery stenosis (results from the EXCELLENT registry).Park KW, Lim WH, Ahn HS, Kang SH, Han JK, Lee SE, Cho JH, Gwon HC, Lee SY, Rhew JY, Kim W, Chae IH, Kim HS.Int J Cardiol. 2013 Oct 3;168(3):2738-44. doi: 10.1016/j.ijcard.2013.03.086. Epub 2013 Apr 25.

• Randomized trial comparing the efficacy between different types of paclitaxel-eluting stents: the comparison of efficacy between COroflex PLEASe ANd Taxus stent (ECO-PLEASANT) randomized controlled trial.Seo JB, Kang SH, Hur SH, Park KW, Youn TJ, Park JS, Yang HM, Lee HY, Kang HJ, Koo BK, Bae JH, Kim SW, Moon KW, Choi JW, Lee SG, Chung WY, Kim SJ, Kim DI, Kim BO, Hyon MS, Park KS, Cha TJ, Yoo CW, Jeon HK, Kim HS.Am Heart J. 2013 May;165(5):733-43. doi: 10.1016/j.ahj.2013.02.009. Epub 2013 Mar 20.

• Paraoxonase 1 gene polymorphism does not affect clopidogrel response variability but is associated with clinical outcome after PCI.Park KW, Park JJ, Kang J, Jeon KH, Kang SH, Han JK, Lee SE, Yang HM, Lee HY, Kang HJ, Koo BK, Oh BH, Park YB, Kim HS.PLoS One. 2013;8(2):e52779. doi: 10.1371/journal.pone.0052779. Epub 2013 Feb 13.

• CYP3A4 genetic status may be associated with increased vulnerability to the inhibitory effect of calcium-channel blockers on clopidogrel.Park JJ, Park KW, Kang J, Jeon KH, Kang SH, Ahn HS, Han JK, Koh JS, Lee SE, Yang HM, Lee HY, Kang HJ, Koo BK, Oh BH, Park YB, Kim HS.Circ J. 2013;77(5):1289-96. doi: 10.1253/circj.cj-12-0682. Epub 2013 Feb 9.

• Safety and efficacy of everolimus- versus sirolimus-eluting stents: a systematic review and meta-analysis of 11 randomized trials.Park KW, Kang SH, Velders MA, Shin DH, Hahn S, Lim WH, Yang HM, Lee HY, Van Boven AJ, Hofma SH, Kang HJ, Koo BK, Oh BH, Park YB, Kandzari DE, Kim HS.Am Heart J. 2013 Feb;165(2):241-50.e4. doi: 10.1016/j.ahj.2012.08.007. Epub 2012 Dec 27.

• Safety and efficacy of second-generation everolimus-eluting Xience V stents versus zotarolimus-eluting resolute stents in real-world practice: patient-related and stent-related outcomes from the multicenter prospective EXCELLENT and RESOLUTE-Korea registries.Park KW, Lee JM, Kang SH, Ahn HS, Yang HM, Lee HY, Kang HJ, Koo BK, Cho J, Gwon HC, Lee SY, Chae IH, Youn TJ, Chae JK, Han KR, Yu CW, Kim HS.J Am Coll Cardiol. 2013 Feb 5;61(5):536-44. doi: 10.1016/j.jacc.2012.11.015. Epub 2012 Dec 26.

• Genetic determinants of clopidogrel responsiveness in Koreans treated with drug-eluting stents.Park JJ, Park KW, Kang J, Jeon KH, Kang SH, Ahn HS, Han JK, Koh JS, Lee SE, Yang HM, Lee HY, Kang HJ, Koo BK, Oh BH, Park YB, Kim HS.Int J Cardiol. 2013 Feb 10;163(1):79-86. doi: 10.1016/j.ijcard.2012.09.075. Epub 2012 Dec 20.

• Cigarette smoking is paradoxically associated with low mortality risk after acute myocardial infarction.Kang SH, Suh JW, Choi DJ, Chae IH, Cho GY, Youn TJ, Cho YS, Yoon CH, Oh IY, Cho MC, Kim YJ, Chae SC, Kim JH, Ahn YK, Jeong MH; KAMIR/KorMI Registry.Nicotine Tob Res. 2013 Jul;15(7):1230-8. doi: 10.1093/ntr/nts248. Epub 2012 Dec 10.

• Multicenter international registry of unprotected left main coronary artery percutaneous coronary intervention with everolimus-eluting stents.Lee MS, Park KW, Kang SH, Sheiban I, Mahmud E, Thani KB, Cheng R, Cho JH, Jin DK, Gwon HC, Chae IH, Aragon J, Gillis K, Stone GW, Kim HS.J Invasive Cardiol. 2012 Jul;24(7):316-9.

• Enhanced clopidogrel response in smokers is reversed after discontinuation as assessed by VerifyNow assay: additional evidence for the concept of 'smokers' paradox'.Park KW, Kang SH, Kang J, Jeon KH, Park JJ, Han JK, Koh JS, Lee SE, Yang HM, Lee HY, Kang HJ, Koo BK, Oh BH, Park YB, Kim HS.Heart. 2012 Jul;98(13):1000-6. doi: 10.1136/heartjnl-2011-301565. Epub 2012 May 9.

• Impact of intravascular ultrasound guidance in routine percutaneous coronary intervention for conventional lesions: data from the EXCELLENT trial.Park KW, Kang SH, Yang HM, Lee HY, Kang HJ, Cho YS, Youn TJ, Koo BK, Chae IH, Kim HS.Int J Cardiol. 2013 Aug 10;167(3):721-6. doi: 10.1016/j.ijcard.2012.03.059. Epub 2012 Apr 4.

• The 'Harmonizing Optimal Strategy for Treatment of coronary artery stenosis - sAfety & effectiveneSS of drug-elUting stents & antiplatelet REgimen' (HOST-ASSURE) trial: study protocol for a randomized controlled trial.Park KW, Park BE, Kang SH, Park JJ, Lee SP, Cha KS, Rhew JY, Jeon HK, Shin ES, Oh JH, Jeong MH, Kim S, Hwang KK, Yoon JH, Lee SY, Park TH, Moon KW, Kwon HM, Chae IH, Kim HS; HOST investigators.Trials. 2012 Mar 31;13:29. doi: 10.1186/1745-6215-13-29.

• Sex differences in management and mortality of patients with ST-elevation myocardial infarction (from the Korean Acute Myocardial Infarction National Registry).Kang SH, Suh JW, Yoon CH, Cho MC, Kim YJ, Chae SC, Yoon JH, Gwon HC, Han KR, Kim JH, Ahn YK, Jeong MH, Kim HS, Choi DJ; KAMIR/KorMI Registry .Am J Cardiol. 2012 Mar 15;109(6):787-93. doi: 10.1016/j.amjcard.2011.11.006. Epub 2011 Dec 22.

• Response to "Sirolimus or paclitaxel drug eluting stent in left main disease: the winner is...".Park KW, Kang SH, Kim HS.Int J Cardiol. 2012 Jan 26;154(2):192-3. doi: 10.1016/j.ijcard.2011.10.079. Epub 2011 Nov 9.

• Comparison between zotarolimus-eluting stents and first generation drug-eluting stents in the treatment of patients with acute ST-segment elevation myocardial infarction.Park KW, Lim WH, Kim JH, Kang SH, Seo JW, Song YB, Hahn JY, Lee HY, Kang HJ, Cho YS, Youn TJ, Koo BK, Choi SH, Chae IH, Gwon HC, Choi DJ, Kim HS.Int J Cardiol. 2013 Jun 5;166(1):118-25. doi: 10.1016/j.ijcard.2011.10.012. Epub 2011 Nov 5.

• Delayed diagnosis of traumatic ventricular septal defect in penetrating chest injury: small evidence on echocardiography makes big difference.Jeon K, Lim WH, Kang SH, Cho I, Kim KH, Kim HK, Kim YJ, Sohn DW.J Cardiovasc Ultrasound. 2010 Mar;18(1):28-30. doi: 10.4250/jcu.2010.18.1.28. Epub 2010 Mar 31.

• Asymptomatic Right Coronary Artery-to-Pulmonary Artery Fistula Incidentally Detected by Transthoracic Echocardiography.Lim WH, Kang SH, Jeon K, Cho I, Kim KH, Hwang SW, Kim HK, Sohn DW.J Cardiovasc Ultrasound. 2009 Sep;17(3):106-9. doi: 10.4250/jcu.2009.17.3.106. Epub 2009 Sep 30.

• Sirolimus- vs. paclitaxel-eluting stents for the treatment of unprotected left main coronary artery stenosis: complete 2-year follow-up of a two-center registry.Park KW, Kang SH, Park KH, Choi DH, Lee HY, Kang HJ, Cho YS, Yeon TJ, Chung WY, Koo BK, Chae IH, Choi DJ, Oh BH, Park YB, Kim HS.Int J Cardiol. 2011 Aug 18;151(1):89-95. doi: 10.1016/j.ijcard.2010.05.001. Epub 2010 Jun 3.

• 'Real world' comparison of drug-eluting stents vs bare metal stents in the treatment of unselected patients with acute ST-segment elevation myocardial infarction.Park KW, Kang SH, Chung WY, Lee HY, Park JS, Kang HJ, Cho YS, Youn TJ, Koo BK, Chae IH, Choi DJ, Hahn S, Park BJ, Kim HS.Circ J. 2010 Jun;74(6):1111-20. doi: 10.1253/circj.cj-09-0936. Epub 2010 Apr 20.

• Coronary artery bypass grafting versus drug-eluting stent implantation for left main coronary artery disease (from a two-center registry).Kang SH, Park KH, Choi DJ, Park KW, Chung WY, Lim C, Kim KB, Kim HS.Am J Cardiol. 2010 Feb 1;105(3):343-51. doi: 10.1016/j.amjcard.2009.09.036.